BANK OF MONTREAL /CAN/ - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 60 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2016. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2017$1,0003800.0%0.00%
Q3 2017$03800.0%0.00%
Q2 2017$03800.0%0.00%
Q1 2017$0
-100.0%
380
-23.5%
0.00%
Q4 2016$1,000
-88.9%
497
-79.4%
0.00%
Q3 2016$9,000
-92.4%
2,417
-92.7%
0.00%
Q2 2016$118,000
+11700.0%
33,037
+13665.4%
0.00%
Q4 2015$1,000
-98.4%
240
-95.2%
0.00%
Q1 2015$64,0005,0000.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2016
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 431,582$4,428,0000.58%
AWM Investment Company, Inc. 234,965$2,411,0000.33%
DAFNA Capital Management LLC 39,800$408,0000.32%
AYM CAPITAL, LLC 15,193$156,0000.12%
CARL DOMINO INC 20,350$209,0000.11%
JW Asset Management, LLC 8,500$87,0000.06%
NumerixS Investment Technologies Inc 13,800$142,0000.05%
FIDUCIARY TRUST INTERNATIONAL LLC 14,100$145,0000.04%
Cubist Systematic Strategies, LLC 15,711$161,0000.01%
REGIONS FINANCIAL CORP 32,000$328,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders